4
Changes in Ownership
Lineage Cell Therapeutics, Inc. Filed Acc 0001209191-17-041267
Director bought 2,000 shares at $2.95 ($5,900)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| ANDREWS DEBORAH J Director | 2017-06-16 | Purchase | +2,000 | $2.95 | $5,900 | 6,000 | D: show line 1 in the form |
| Open-market purchases · 2,000 sh · avg $2.95 · $5,900 | |||||||
Loading xslF345X03/doc4.xml…